Liaoning Cheng Da Co Ltd (600739) - Net Assets

Latest as of March 2026: CN¥33.17 Billion CNY ≈ $4.85 Billion USD

Based on the latest financial reports, Liaoning Cheng Da Co Ltd (600739) has net assets worth CN¥33.17 Billion CNY (≈ $4.85 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥50.48 Billion ≈ $7.39 Billion USD) and total liabilities (CN¥17.32 Billion ≈ $2.53 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Liaoning Cheng Da Co Ltd to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥33.17 Billion
% of Total Assets 65.7%
Annual Growth Rate 19.4%
5-Year Change 3.18%
10-Year Change 62.35%
Growth Volatility 32.48

Liaoning Cheng Da Co Ltd - Net Assets Trend (1993–2025)

This chart illustrates how Liaoning Cheng Da Co Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Liaoning Cheng Da Co Ltd to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Liaoning Cheng Da Co Ltd (1993–2025)

The table below shows the annual net assets of Liaoning Cheng Da Co Ltd from 1993 to 2025. For live valuation and market cap data, see 600739 company net worth.

Year Net Assets Change
2025-12-31 CN¥32.48 Billion
≈ $4.75 Billion		 +0.29%
2024-12-31 CN¥32.38 Billion
≈ $4.74 Billion		 +2.40%
2023-12-31 CN¥31.62 Billion
≈ $4.63 Billion		 -1.88%
2022-12-31 CN¥32.23 Billion
≈ $4.72 Billion		 +2.39%
2021-12-31 CN¥31.48 Billion
≈ $4.61 Billion		 +25.88%
2020-12-31 CN¥25.01 Billion
≈ $3.66 Billion		 +9.01%
2019-12-31 CN¥22.94 Billion
≈ $3.36 Billion		 +6.15%
2018-12-31 CN¥21.61 Billion
≈ $3.16 Billion		 +1.13%
2017-12-31 CN¥21.37 Billion
≈ $3.13 Billion		 +6.82%
2016-12-31 CN¥20.00 Billion
≈ $2.93 Billion		 +7.05%
2015-12-31 CN¥18.69 Billion
≈ $2.73 Billion		 +25.50%
2014-12-31 CN¥14.89 Billion
≈ $2.18 Billion		 +25.68%
2013-12-31 CN¥11.85 Billion
≈ $1.73 Billion		 +7.21%
2012-12-31 CN¥11.05 Billion
≈ $1.62 Billion		 +7.69%
2011-12-31 CN¥10.26 Billion
≈ $1.50 Billion		 +27.17%
2010-12-31 CN¥8.07 Billion
≈ $1.18 Billion		 +17.49%
2009-12-31 CN¥6.87 Billion
≈ $1.01 Billion		 +29.34%
2008-12-31 CN¥5.31 Billion
≈ $777.04 Million		 +9.89%
2007-12-31 CN¥4.83 Billion
≈ $707.12 Million		 +176.80%
2006-12-31 CN¥1.75 Billion
≈ $255.46 Million		 +35.57%
2005-12-31 CN¥1.29 Billion
≈ $188.44 Million		 +6.21%
2004-12-31 CN¥1.21 Billion
≈ $177.42 Million		 +4.01%
2003-12-31 CN¥1.17 Billion
≈ $170.58 Million		 +29.55%
2002-12-31 CN¥899.86 Million
≈ $131.68 Million		 +8.73%
2001-12-31 CN¥827.62 Million
≈ $121.11 Million		 +12.33%
2000-12-31 CN¥736.76 Million
≈ $107.81 Million		 +19.06%
1999-12-31 CN¥618.82 Million
≈ $90.55 Million		 +27.49%
1998-12-31 CN¥485.38 Million
≈ $71.03 Million		 +31.14%
1997-12-31 CN¥370.14 Million
≈ $54.16 Million		 +40.48%
1996-12-31 CN¥263.49 Million
≈ $38.56 Million		 +87.04%
1995-12-31 CN¥140.88 Million
≈ $20.61 Million		 +15.04%
1994-12-31 CN¥122.46 Million
≈ $17.92 Million		 +9.83%
1993-12-31 CN¥111.50 Million
≈ $16.32 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Liaoning Cheng Da Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1863799661187.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥18.64 Billion 64.75%
Other Components CN¥10.15 Billion 35.25%
Total Equity CN¥28.78 Billion 100.00%

Liaoning Cheng Da Co Ltd Competitors by Market Cap

The table below lists competitors of Liaoning Cheng Da Co Ltd ranked by their market capitalization.

Company Market Cap
Feng Tay Enterprises Co Ltd
TW:9910
 $2.26 Billion
Shenzhen Bluetrum Technology Co. Ltd. A
SHG:688332
 $2.26 Billion
Willfar Information Technology Co Ltd
SHG:688100
 $2.26 Billion
Hillenbrand Inc
NYSE:HI
 $2.26 Billion
Transwarp Technology (Shanghai) Co. Ltd. A
SHG:688031
 $2.26 Billion
Shandong Gettop Acoustic Co Ltd
SHE:002655
 $2.26 Billion
Chongqing Fuling Electric Power Industrial Co Ltd
SHG:600452
 $2.26 Billion
Eaglerise Electric & Electronic China Co Ltd Class A
SHE:002922
 $2.25 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Liaoning Cheng Da Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 29,299,302,070 to 28,784,488,407, a change of -514,813,663 (-1.8%).
  • Net income of 736,554,408 contributed positively to equity growth.
  • Dividend payments of 618,965,162 reduced retained earnings.
  • Other comprehensive income decreased equity by 5,656,395,490.
  • Other factors increased equity by 5,023,992,581.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥736.55 Million +2.56%
Dividends Paid CN¥618.97 Million -2.15%
Other Comprehensive Income CN¥-5.66 Billion -19.65%
Other Changes CN¥5.02 Billion +17.45%
Total Change CN¥- -1.76%

Book Value vs Market Value Analysis

This analysis compares Liaoning Cheng Da Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.54x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 121.79x to 0.54x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1993-12-31 CN¥0.08 CN¥10.09 x
1994-12-31 CN¥0.09 CN¥10.09 x
1995-12-31 CN¥0.10 CN¥10.09 x
1996-12-31 CN¥0.19 CN¥10.09 x
1997-12-31 CN¥0.26 CN¥10.09 x
1998-12-31 CN¥0.36 CN¥10.09 x
1999-12-31 CN¥0.45 CN¥10.09 x
2000-12-31 CN¥0.53 CN¥10.09 x
2001-12-31 CN¥0.60 CN¥10.09 x
2002-12-31 CN¥0.65 CN¥10.09 x
2003-12-31 CN¥0.83 CN¥10.09 x
2004-12-31 CN¥0.86 CN¥10.09 x
2005-12-31 CN¥0.91 CN¥10.09 x
2006-12-31 CN¥1.22 CN¥10.09 x
2007-12-31 CN¥3.32 CN¥10.09 x
2008-12-31 CN¥3.65 CN¥10.09 x
2009-12-31 CN¥4.76 CN¥10.09 x
2010-12-31 CN¥5.58 CN¥10.09 x
2011-12-31 CN¥7.04 CN¥10.09 x
2012-12-31 CN¥7.60 CN¥10.09 x
2013-12-31 CN¥8.16 CN¥10.09 x
2014-12-31 CN¥9.60 CN¥10.09 x
2015-12-31 CN¥11.52 CN¥10.09 x
2016-12-31 CN¥12.13 CN¥10.09 x
2017-12-31 CN¥13.10 CN¥10.09 x
2018-12-31 CN¥13.22 CN¥10.09 x
2019-12-31 CN¥14.10 CN¥10.09 x
2020-12-31 CN¥15.73 CN¥10.09 x
2021-12-31 CN¥18.30 CN¥10.09 x
2022-12-31 CN¥18.83 CN¥10.09 x
2023-12-31 CN¥18.53 CN¥10.09 x
2024-12-31 CN¥19.25 CN¥10.09 x
2025-12-31 CN¥18.82 CN¥10.09 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Liaoning Cheng Da Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 2.56%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.44%
  • • Asset Turnover: 0.20x
  • • Equity Multiplier: 1.70x
  • Recent ROE (2.56%) is below the historical average (13.38%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1993 23.69% 4.06% 1.53x 3.83x CN¥15.26 Million
1994 29.39% 3.25% 2.66x 3.40x CN¥23.75 Million
1995 26.18% 3.43% 2.50x 3.05x CN¥22.44 Million
1996 16.76% 4.29% 2.00x 1.95x CN¥17.65 Million
1997 21.14% 6.68% 1.67x 1.89x CN¥38.62 Million
1998 12.56% 5.66% 1.37x 1.62x CN¥12.31 Million
1999 22.03% 10.16% 1.42x 1.53x CN¥73.24 Million
2000 24.08% 14.05% 0.96x 1.79x CN¥100.59 Million
2001 14.09% 7.60% 1.07x 1.74x CN¥32.77 Million
2002 6.84% 2.73% 1.19x 2.10x CN¥-27.53 Million
2003 3.13% 1.25% 1.19x 2.11x CN¥-76.91 Million
2004 5.22% 1.67% 1.45x 2.16x CN¥-55.28 Million
2005 7.12% 1.51% 1.82x 2.59x CN¥-35.12 Million
2006 31.32% 9.32% 1.55x 2.16x CN¥350.88 Million
2007 45.73% 38.61% 0.85x 1.40x CN¥1.65 Billion
2008 18.95% 18.35% 0.78x 1.33x CN¥443.66 Million
2009 20.67% 33.37% 0.48x 1.29x CN¥692.39 Million
2010 16.61% 24.00% 0.51x 1.35x CN¥500.82 Million
2011 23.44% 23.32% 0.67x 1.51x CN¥1.29 Billion
2012 6.71% 6.75% 0.65x 1.54x CN¥-341.28 Million
2013 7.60% 8.18% 0.58x 1.61x CN¥-267.72 Million
2014 6.04% 8.80% 0.46x 1.51x CN¥-532.80 Million
2015 2.95% 5.63% 0.34x 1.53x CN¥-1.23 Billion
2016 5.11% 10.83% 0.26x 1.79x CN¥-908.49 Million
2017 7.21% 10.33% 0.39x 1.77x CN¥-558.25 Million
2018 3.80% 4.00% 0.54x 1.77x CN¥-1.26 Billion
2019 5.51% 6.70% 0.45x 1.82x CN¥-967.78 Million
2020 11.52% 16.35% 0.43x 1.63x CN¥365.28 Million
2021 7.72% 11.75% 0.38x 1.72x CN¥-639.31 Million
2022 4.26% 8.40% 0.30x 1.68x CN¥-1.65 Billion
2023 0.81% 2.16% 0.23x 1.63x CN¥-2.65 Billion
2024 0.72% 1.86% 0.24x 1.63x CN¥-2.72 Billion
2025 2.56% 7.44% 0.20x 1.70x CN¥-2.14 Billion

Industry Comparison

This section compares Liaoning Cheng Da Co Ltd's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $7,682,611,937
  • Average return on equity (ROE) among peers: 12.83%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Liaoning Cheng Da Co Ltd (600739) CN¥33.17 Billion 23.69% 0.52x $2.26 Billion
China National Accord Medicines Corp Ltd (000028) $20.76 Billion 3.10% 1.29x $1.60 Billion
Shenzhen Glory Medical Co Ltd (002551) $2.82 Billion 2.12% 0.68x $348.90 Million
Shandong Realcan Pharmaceutical Co Ltd (002589) $9.69 Billion 1.35% 1.72x $581.29 Million
China National Accord Medicines Corp Ltd (200028) $393.72 Million 9.08% 1.72x $125.51 Million
Qingdao Baheal Medical INC. (301015) $1.31 Billion 16.08% 1.63x $1.64 Billion
China Meheco Co Ltd (600056) $102.28 Million 43.06% 1.96x $1.99 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) $23.14 Billion 14.87% 1.22x $4.27 Billion
China National Medicines Corp Ltd (600511) $9.46 Billion 12.07% 1.13x $3.00 Billion
Jointown Pharmaceutical Group Co Ltd (600998) $1.48 Billion 13.72% 2.87x $3.56 Billion

About Liaoning Cheng Da Co Ltd

SHG:600739 China Medical Distribution
Market Cap
$2.26 Billion
CN¥15.43 Billion CNY
Market Cap Rank
#5914 Global
#1214 in China
Share Price
CN¥10.09
Change (1 day)
-1.46%
52-Week Range
CN¥9.91 - CN¥13.34
All Time High
CN¥30.21
Categories
Companies in China Medical Distribution
About

Liaoning Cheng Da Co., Ltd. engages in biopharmaceutical, financial investment, supply chain, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also of… Read more